Scientists from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) have identified why certain lung cancer cells become highly resistant to treatment after developing mutations in a key gene ...

SINGAPORE – Scientists from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) have identified why certain lung cancer cells become highly ...

Editor’s note: This is a previously posted video, and the below is an automatically generated transcript to be used for informational purposes. Please notify editor@healio.com if there are concerns ...

In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for expediting diagnoses and guiding patient treatment.

Large cell carcinoma is aggressive, requiring early detection through imaging and biopsy for optimal treatment outcomes.

The US Food and Drug Administration (FDA) today approved the first blood-based genetic test that can detect epidermal growth factor receptor (EGFR) gene mutations in non-small cell lung cancer ...

Jorge Manchola, a retired Air Force staff sergeant, was diagnosed with stage 4 lung cancer in 2023. The cancer had spread to ...

While the statistics remain stark—lung cancer is the most common type of cancer worldwide and has the highest death ...

From new imaging and targeted therapies to patient journeys, 2025 highlighted key advances and personal stories in lung ...

In summer 2026, scientists at the University of Oxford and University College London plan to begin a first-of-its-kind clinical trial of an experimental lung cancer prevention vaccine called LungVax.

We currently know that COPD, and specifically emphysema, is not just a lung disease found alongside lung cancer; it increases ...